{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "62332-417",
      "generic_name": "Lamotrigine",
      "labeler_name": "Alembic Pharmaceuticals Inc.",
      "brand_name": "Lamotrigine",
      "active_ingredients": [
        {
          "name": "LAMOTRIGINE",
          "strength": "200 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "62332-417-30",
          "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-417-30)",
          "marketing_start_date": "20241007",
          "sample": false
        },
        {
          "package_ndc": "62332-417-91",
          "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-417-91)",
          "marketing_start_date": "20241007",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Alembic Pharmaceuticals Inc."
        ],
        "rxcui": [
          "900156",
          "1098608",
          "1146690"
        ],
        "spl_set_id": [
          "4bd7193f-a81a-4909-90c2-7f324fc6ddfd"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0362332419302",
          "0362332417308",
          "0362332418305"
        ],
        "nui": [
          "N0000175753",
          "N0000008486",
          "N0000175751",
          "N0000187061",
          "N0000000191"
        ],
        "pharm_class_epc": [
          "Anti-epileptic Agent [EPC]",
          "Mood Stabilizer [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
        ],
        "pharm_class_moa": [
          "Organic Cation Transporter 2 Inhibitors [MoA]",
          "Dihydrofolate Reductase Inhibitors [MoA]"
        ],
        "unii": [
          "U3H27498KS"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, EXTENDED RELEASE",
      "spl_id": "e0d81ac2-c195-4adb-a249-43befe697ee6",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20241007",
      "product_id": "62332-417_e0d81ac2-c195-4adb-a249-43befe697ee6",
      "application_number": "ANDA211821",
      "brand_name_base": "Lamotrigine",
      "pharm_class": [
        "Anti-epileptic Agent [EPC]",
        "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
        "Dihydrofolate Reductase Inhibitors [MoA]",
        "Mood Stabilizer [EPC]",
        "Organic Cation Transporter 2 Inhibitors [MoA]"
      ]
    }
  ]
}